BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 54 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,200 | -79.9% | 75,000 | -85.2% | 0.00% | -40.0% |
Q2 2023 | $20,902 | +248.4% | 507,159 | +576.2% | 0.01% | +66.7% |
Q1 2023 | $6,000 | +199900.0% | 75,000 | 0.0% | 0.00% | +200.0% |
Q4 2022 | $3 | -100.0% | 75,000 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $11,000 | – | 75,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Radcliffe Capital Management, L.P. | 200,049 | $2,007,000 | 0.05% |
Q Global Advisors, LLC | 195,489 | $18,000 | 0.01% |
RAMIUS ADVISORS LLC | 196,073 | $16,000 | 0.01% |
EHP Funds Inc. | 137,276 | $20,000 | 0.00% |
Telemetry Investments, L.L.C. | 33,303 | $3,000 | 0.00% |
MARSHALL WACE, LLP | 190,150 | $1,930,000 | 0.00% |
PERISCOPE CAPITAL INC. | 735,572 | $97,000 | 0.00% |
Spartan Fund Management Inc. | 75,000 | $11,000 | 0.00% |
Union Square Park Capital Management, LLC | 25,000 | $2,000 | 0.00% |
KIM, LLC | 250,000 | $36,000 | 0.00% |